Artivion, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı

Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.

Devamını oku

Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.

## History

Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.

In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.

In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.

In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.

In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.

In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.

In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.

Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗

Wikidata ↗

AORT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

Fiyat

$28.89

Piyasa Değeri

$1.44B

P/E (TTM)

139.4

EPS (TTM)

$0.21

Gelir (TTM)

$441M

Temettü Verimi

—

ROE

2.2%

D/E Borç/Özsermaye

0.5

52 Haftlık Aralık

$19 – $48

AORT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Gelir ve Net Gelir $441M

2016-12-31 → 2025-12-31

Hisse Başına Kâr $0.21

2016-12-31 → 2025-12-31

Serbest Nakit Akışı $839.0K

2016-12-31 → 2025-12-31

Marjlar 2.2%

2016-12-31 → 2025-12-31

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik

5 Yıllık trend

AORT

Akran Ortalaması

P/E (TTM)

139.4

38.5

P/S (TTM) (F/S (TTM))

3.3

2.5

P/B (F/D)

3.2

4.8

EV / EBITDA

28.4

—

Price / FCF (Fiyat / Serbest Nakit Akışı)

1720.8

—

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik

5 Yıllık trend

AORT

Akran Ortalaması

Gross Margin (Brüt Kar Marjı)

64.4%

58.7%

Operating Margin (Faaliyet Kâr Marjı)

7.6%

—

Net Profit Margin (Net Kâr Marjı)

2.2%

-12.6%

ROA

1.2%

-11.8%

ROE

2.2%

-37.7%

ROIC

3.4%

—

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik

5 Yıllık trend

AORT

Akran Ortalaması

Debt / Equity (Borç / Öz Sermaye)

0.5

25.5

Current Ratio (Cari Oran)

3.5

Quick Ratio (Cari Oran)

1.5

—

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik

5 Yıllık trend

AORT

Akran Ortalaması

Revenue YoY (Gelir Yıllık Bazda)

13.6%

—

Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)

12.0%

—

Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)

11.8%

—

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik

5 Yıllık trend

AORT

Akran Ortalaması

EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))

$0.21

—

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik

5 Yıllık trend

AORT

Akran Ortalaması

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

Temettü Verimi

—

Temettü Ödeme Oranı

—

5 Yıllık Temettü CAGR

—

Ex-tarihi	Miktar
09 Aralık 2015	$0,0300
09 Eylül 2015	$0,0300
10 Haziran 2015	$0,0300
11 Mart 2015	$0,0300
10 Aralık 2014	$0,0300
10 Eylül 2014	$0,0300
11 Haziran 2014	$0,0300
12 Mart 2014	$0,0280
11 Aralık 2013	$0,0280
11 Eylül 2013	$0,0280
12 Haziran 2013	$0,0280
12 Mart 2013	$0,0250
12 Aralık 2012	$0,0250
12 Eylül 2012	$0,0250

AORT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

AL 14 analist

Güçlü Al 5 35,7%
Al 8 57,1%
Tut 1 7,1%
Sat 0 0,0%
Güçlü Sat 0 0,0%

12 Aylık Fiyat Hedefi

8 analist · 2026-08-18

Medyan $42.00

← Tüm hedeflerin altında $28.89

Düşük $38.00

Yüksek $48.00

Medyan hedef $42.00 +45,4%

Ortalama hedef $42.15 +45,9%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Ort. Sürpriz

-0.02%

Dönem	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	$-0.28	$0.01	-0.29%
31 Mart 2026	$0.03	$0.05	-0.02%
31 Aralık 2025	$0.05	$0.08	-0.03%
30 Eylül 2025	$0.06	$0.02	0.04%
30 Haziran 2025	$0.08	$-0.00	0.08%
31 Mart 2025	$-0.01	$-0.12	0.11%

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
AORT	$2.25B	217.2	13.6%	2.2%	2.2%	64.4%
TNDM	$1.50B	-7.2	7.9%	-20.2%	-141.9%	53.8%
CNMD	$1.27B	26.9	5.2%	3.4%	4.6%	54.6%
ATEC	$3.16B	-21.9	24.9%	-18.8%	-792.1%	69.6%
ENOV	$1.52B	-1.3	6.7%	-52.7%	-58.5%	59.8%
IART	—	-1.8	1.5%	-31.6%	-49.6%	—
KMTS	$1.21B	-8.5	59.0%	-138.4%	-62.1%	51.4%
PRCT	$1.77B	-18.3	37.2%	-31.0%	-25.4%	63.7%
IRMD	$1.24B	55.6	14.4%	26.8%	23.8%	76.8%
ABT	$250.18B	33.7	5.7%	14.7%	13.1%	—

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Gelir Tablosu 18

AORT için Yıllık Gelir Tablosu verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$441M	$389M	$354M	$314M	$299M	$253M	$276M	$263M	$190M	$180M	$146M	$145M
Cost of Revenue	$157M	$140M	$125M	$111M	$101M	$85M	$93M	$90M	$61M	$61M	$55M	$53M
Gross Profit	$284M	$249M	$229M	$203M	$198M	$168M	$183M	$173M	$129M	$119M	$91M	$91M
R&D Expense	$31M	$28M	$29M	$39M	$36M	$24M	$23M	$23M	$19M	$13M	$10M	$9M
SG&A Expense	$226M	$181M	$209M	$157M	$170M	$141M	$143M	$141M	$101M	$92M	$75M	$74M
Operating Expenses	$257M	$210M	$238M	$196M	$205M	$165M	$166M	$164M	$121M	$105M	$85M	$82M
Operating Income	$34M	$39M	$6M	$6M	$8M	$2M	$17M	$9M	$8M	$22M	$5M	$9M
Interest Expense	·	·	$25M	$18M	$17M	$17M	$15M	$16M	$5M	$3M	$62.0K	$175.0K
Interest Income	$763.0K	$1M	$1M	$147.0K	$79.0K	$217.0K	$738.0K	$226.0K	$212.0K	$72.0K	$45.0K	$50.0K
Other Non-op	$10M	$-10M	$-3M	$-3M	$-6M	$-3M	$-1M	$-141.0K	$260.0K	$-437.0K	$-484.0K	$-540.0K
Pretax Income	$15M	$-8M	$-22M	$-15M	$-15M	$-17M	$2M	$-6M	$4M	$18M	$6M	$9M
Income Tax	$5M	$6M	$9M	$4M	$7.0K	$-492.0K	$-76.0K	$-4M	$-143.0K	$8M	$2M	$1M
Net Income	$10M	$-13M	$-31M	$-19M	$-15M	$-17M	$2M	$-3M	$4M	$11M	$4M	$7M
EPS (Basic)	$0.22	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.08	$0.11	$0.33	$0.14	$0.26
EPS (Diluted)	$0.21	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.08	$0.11	$0.32	$0.14	$0.25
Shares (Basic)	45,335,000	41,676,000	40,743,000	40,032,000	38,983,000	37,861,000	37,118,000	36,412,000	33,008,000	31,855,000	27,744,000	27,379,000
Shares (Diluted)	47,162,000	41,676,000	40,743,000	40,032,000	38,983,000	37,861,000	37,860,000	36,412,000	34,163,000	32,822,000	28,542,000	28,313,000
EBITDA	$56M	$63M	$29M	$29M	$32M	$23M	$35M	$27M	$18M	$30M	·	$15M

Bilanço 28

AORT için Yıllık Bilanço verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$65M	$53M	$59M	$39M	$55M	$61M	$34M	$41M	$40M	$57M	$38M	$33M
Receivables	$90M	$79M	$72M	$62M	$53M	$46M	$53M	$47M	$48M	$28M	$23M	$21M
Inventory	$92M	$80M	$82M	$74M	$77M	$73M	$53M	$45M	$47M	$26M	$15M	$13M
Prepaid Expense	$43M	$19M	$16M	$18M	$15M	$14M	$12M	$7M	$5M	$3M	$5M	$5M
Current Assets	$358M	$290M	$281M	$247M	$248M	$235M	$187M	$179M	$179M	$147M	$110M	$106M
PP&E (Net)	$65M	$36M	$38M	$39M	$38M	$33M	$32M	$31M	$34M	$19M	$11M	$12M
PP&E (Gross)	·	·	·	$127M	$120M	$111M	$103M	$96M	$93M	$74M	$64M	$62M
Accum. Depreciation	·	·	·	$88M	$82M	$78M	$71M	$65M	$60M	$55M	$53M	$50M
Goodwill	$254M	$241M	$247M	$244M	$250M	$260M	$187M	$189M	$188M	$78M	$11M	$11M
Intangibles	$124M	$128M	$143M	$151M	$167M	$186M	$115M	$118M	$130M	$1M	$1M	$2M
Other Non-current Assets	$15M	$24M	$9M	$7M	$8M	$15M	$14M	$8M	$7M	$2M	$6M	$5M
Total Assets	$885M	$789M	$792M	$763M	$793M	$789M	$606M	$571M	$590M	$316M	$181M	$176M
Accounts Payable	$16M	$18M	$13M	$12M	$10M	$10M	$10M	$8M	$10M	$6M	$5M	$4M
Accrued Liabilities	$16M	$12M	$10M	$12M	$8M	$7M	$7M	$7M	$12M	$5M	$3M	$3M
Current Liabilities	$102M	$67M	$58M	$50M	$45M	$60M	$45M	$35M	$43M	$30M	$20M	$21M
Capital Leases	$34M	$40M	$44M	$41M	$45M	$14M	$18M	$0	$7M	$11.0K	·	·
Deferred Tax	$24M	$20M	$22M	$24M	$29M	$35M	$26M	$27M	$30M	$7.0K	·	·
Other Non-current Liabilities	$9M	$8M	$7M	$7M	$6M	$7M	$7M	$7M	$8M	$5M	$3M	$3M
Total Liabilities	$437M	$513M	$511M	$478M	$492M	$461M	$320M	$296M	$313M	$107M	$26M	$27M
Long-term Debt	$215M	$314M	$307M	$308M	$309M	$292M	$216M	$217M	$219M	$72M	·	·
Total Debt	$215M	$314M	$307M	$308M	$309M	$292M	$216M	$217M	$219M	$72M	·	·
Common Stock	$493.0K	$434.0K	$426.0K	$418.0K	$414.0K	$404.0K	$390.0K	$385.0K	$376.0K	$342.0K	$298.0K	$292.0K
Retained Earnings	$-51M	$-61M	$-48M	$-17M	$2M	$20M	$37M	$35M	$38M	$34M	$23M	$23M
Treasury Stock	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$13M	$12M	$11M	$9M
AOCI	$-3M	$-25M	$-12M	$-22M	$-10M	$7M	$-9M	$-6M	$2M	$-429.0K	$-76.0K	$-121.0K
Stockholders' Equity	$448M	$276M	$282M	$284M	$301M	$329M	$286M	$275M	$277M	$209M	$155M	$149M
Liabilities + Equity	$885M	$789M	$792M	$763M	$793M	$789M	$606M	$571M	$590M	$316M	$181M	$176M
Shares Outstanding	49,330,000	43,432,000	42,569,000	41,830,000	41,397,000	40,394,000	39,018,000	38,463,000	37,618,000	34,230,000	29,766,000	29,229,000

Nakit Akışı 19

AORT için Yıllık Nakit Akışı verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$22M	$24M	$23M	$22M	$24M	$21M	$18M	$18M	$10M	$8M	$6M	$6M
Stock-based Comp	$24M	$14M	$14M	$12M	$11M	$7M	$9M	$6M	$7M	$6M	$5M	$3M
Deferred Tax	$37.0K	$-2M	$-1M	$-885.0K	$-6M	$816.0K	$-2M	$-6M	$-1M	$3M	$1M	$173.0K
Amort. of Intangibles	$14M	$16M	$15M	$15M	$17M	$14M	$11M	$11M	$5M	$4M	$2M	$2M
Other Non-cash	$-17M	$-1M	$13M	$-20M	$-17M	$611.0K	$-11M	$-5M	$-8M	$-8M	·	$-9M
Operating Cash Flow	$40M	$22M	$19M	$-5M	$-3M	$12M	$16M	$10M	$11M	$20M	$11M	$8M
CapEx	$39M	$11M	$10M	$11M	$13M	$7M	$8M	$6M	$7M	$6M	$3M	$4M
Investing Cash Flow	$-42M	$-28M	$-502.0K	$-11M	$6M	$-73M	$-24M	$-7M	$-171M	$-79M	$-4M	·
Debt Issued	$0	$184M	$0	$0	·	·	·	·	·	·	·	·
Net Debt Issued	$-210.0K	$-28M	$-3M	·	·	·	·	·	·	·	·	·
Stock Issued	$13M	$6M	$4M	$3M	$4M	$2M	$5M	$4M	$3M	$2M	$2M	$3M
Stock Repurchased	·	·	·	·	·	·	·	·	·	·	·	$6M
Net Stock Activity	$13M	$6M	$4M	$3M	$4M	$2M	$5M	$4M	$3M	$2M	·	$-3M
Dividends Paid	·	·	·	·	·	·	·	·	·	·	$3M	$3M
Financing Cash Flow	$11M	$2M	$865.0K	$-2M	$-12M	$94M	$-1M	$-3M	$143M	$73M	$-3M	·
Net Change in Cash	$11M	$-5M	$20M	$-16M	$-7M	$28M	$-8M	$1M	$-17M	$14M	$4M	$-4M
Taxes Paid	$3M	·	·	·	·	·	·	·	·	·	$145.0K	$3M
Free Cash Flow	$839.0K	$11M	$11M	$-14M	$-16M	$5M	$8M	$4M	$4M	$14M	·	$4M
Levered FCF	·	·	$-25M	$-38M	$-33M	$-11M	$-8M	$-3M	$-925.8K	$12M	·	·

Kârlılık 8

AORT için Yıllık Kârlılık verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	64.4%	64.0%	64.7%	64.5%	66.1%	66.3%	66.3%	65.8%	67.8%	65.9%	·	63.1%
Operating Margin	7.6%	10.0%	1.6%	2.0%	2.7%	0.96%	6.2%	3.5%	4.2%	12.1%	·	6.1%
Net Margin	2.2%	-3.4%	-8.7%	-6.1%	-5.0%	-6.6%	0.62%	-1.1%	1.9%	6.0%	·	5.1%
Pretax Margin	3.4%	-1.9%	-6.1%	-4.8%	-5.0%	-6.8%	0.60%	-2.4%	1.9%	10.2%	·	6.0%
EBITDA Margin	12.7%	16.2%	8.1%	9.1%	10.7%	9.1%	12.8%	10.4%	9.3%	16.7%	·	10.3%
ROA	1.2%	-1.7%	-4.0%	-2.5%	-1.9%	-2.4%	0.29%	-0.49%	0.82%	4.3%	·	4.2%
ROE	2.2%	-4.6%	-11.1%	-7.1%	-4.9%	-5.1%	0.61%	-1.0%	1.5%	5.9%	·	5.0%
ROIC	3.4%	11.7%	1.4%	1.3%	1.3%	0.38%	3.6%	0.84%	1.7%	4.5%	·	5.0%

Likidite ve Solventlik 5

AORT için Yıllık Likidite ve Solventlik verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	3.5	4.3	4.9	5.0	5.5	3.9	4.1	5.2	4.2	4.9	·	5.1
Quick Ratio	1.5	2.0	2.3	2.0	2.4	1.8	1.9	2.6	2.0	2.8	·	2.6
Debt / Equity	0.5	1.1	1.1	1.1	1.0	0.9	0.8	0.8	0.8	0.3	·	·
LT Debt / Equity	0.5	1.1	1.1	1.1	1.0	0.9	0.8	0.8	0.8	0.3	·	·
Interest Coverage	·	·	0.2	0.3	0.5	0.1	1.1	0.6	1.6	7.3	·	·

Verimlilik 3

AORT için Yıllık Verimlilik verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.5	0.5	0.5	0.4	0.4	0.4	0.5	0.5	0.4	0.7	·	0.8
Inventory Turnover	1.8	1.7	1.6	1.5	1.4	1.4	1.9	1.9	1.7	3.0	·	4.7
Receivables Turnover	5.2	5.1	5.3	5.5	6.0	5.1	5.5	5.6	5.0	7.0	·	7.4

Hisse Başına 7

AORT için Yıllık Hisse Başına verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$9.09	$6.36	$6.62	$6.80	$7.26	$8.14	$7.32	$7.15	$7.37	$6.11	·	$5.09
Revenue / Share	$9.36	$9.32	$8.69	$7.84	$7.67	$6.69	$7.30	$7.22	$5.55	$5.50	·	$5.11
Cash Flow / Share	$0.85	$0.53	$0.46	$-0.13	$-0.07	$0.33	$0.42	$0.27	$0.32	$0.60	·	$0.29
Cash / Share	$1.32	$1.23	$1.38	$0.94	$1.33	$1.52	$0.87	$1.08	$1.06	$1.65	·	$1.14
Dividend / Share	·	·	·	·	·	·	$0	$0	$0	$0	$0	$0
Dividend Paid / Share	·	·	·	·	·	·	·	·	·	·	$0	$0
EPS (TTM)	$0.21	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.08	$0.11	$0.32	$0.14	$0.25

Büyüme Oranları 3

AORT için Yıllık Büyüme Oranları verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	13.6%	9.8%	12.8%	5.0%	18.0%	·	·	·	·	·	·	·
Revenue CAGR 3Y	12.0%	9.1%	11.8%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	11.8%	·	·	·	·	·	·	·	·	·	·	·

Değerleme (TTM) 17

AORT için Yıllık Değerleme (TTM) verileri
Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$441M	$389M	$354M	$314M	$299M	$253M	$276M	$263M	$190M	$180M	$146M	$145M
Net Income TTM	$10M	$-13M	$-31M	$-19M	$-15M	$-17M	$2M	$-3M	$4M	$11M	$4M	$7M
Market Cap	$2.25B	$1.24B	$761M	$507M	$842M	$954M	$1.06B	$1.09B	$720M	$656M	·	$331M
Enterprise Value	$2.40B	$1.50B	$1.01B	$776M	$1.10B	$1.18B	$1.24B	$1.27B	$899M	$670M	·	·
P/E	217.2	-89.3	-23.8	-25.2	-53.6	-53.7	541.8	-354.8	174.1	59.8	77.0	45.3
P/S	5.1	3.2	2.2	1.6	2.8	3.8	3.8	4.2	3.8	3.6	·	2.3
P/B	5.0	4.5	2.7	1.8	2.8	2.9	3.7	4.0	2.6	3.1	·	2.2
P / Tangible Book	31.9	·	·	·	·	·	·	·	·	·	·	·
P / Cash Flow	56.4	55.8	40.4	-98.4	-325.9	77.1	66.8	110.5	66.7	33.2	·	40.8
P / FCF	2681.7	112.4	66.8	-35.8	-53.7	189.2	136.3	266.6	172.7	48.5	·	87.0
EV / EBITDA	42.7	23.8	35.0	27.1	34.2	51.1	35.0	46.2	50.8	22.2	·	·
EV / FCF	2860.7	136.0	88.6	-54.7	-70.0	234.9	159.8	309.4	215.6	49.6	·	·
EV / Revenue	5.4	3.9	2.9	2.5	3.7	4.7	4.5	4.8	4.7	3.7	·	·
Dividend Yield	·	·	·	·	·	·	·	·	·	·	·	0.99%
Earnings Yield	0.46%	-1.1%	-4.2%	-4.0%	-1.9%	-1.9%	0.18%	-0.28%	0.57%	1.7%	1.3%	2.2%
Payout Ratio	·	·	·	·	·	·	·	·	·	·	·	45.0%
Annual Payout	·	·	·	·	·	·	·	·	·	·	$3M	$3M

Gelir Tablosu 18

AORT için Çeyreklik Gelir Tablosu verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$126M	$116M	$116M	$113M	$113M	$99M	$97M	$96M	$98M	$97M	$94M	$88M	$89M	$83M	$79M	$77M
Cost of Revenue	$45M	$41M	$43M	$39M	$40M	$35M	$36M	$35M	$35M	$34M	$33M	$32M	$31M	$30M	$29M	$28M
Gross Profit	$81M	$75M	$73M	$74M	$73M	$64M	$62M	$61M	$63M	$63M	$61M	$56M	$58M	$54M	$51M	$49M
R&D Expense	$9M	$9M	$9M	$8M	$7M	$7M	$7M	$7M	$7M	$7M	$8M	$6M	$7M	$7M	$8M	$12M
SG&A Expense	$80M	$61M	$57M	$57M	$58M	$55M	$51M	$50M	$49M	$31M	$50M	$51M	$57M	$50M	$38M	$41M
Operating Expenses	$89M	$70M	$66M	$65M	$65M	$61M	$59M	$57M	$57M	$38M	$58M	$58M	$65M	$58M	$47M	$53M
Operating Income	$-8M	$6M	$11M	$13M	$8M	$2M	$3M	$4M	$7M	$25M	$3M	$-1M	$8M	$-4M	$4M	$-4M
Interest Expense	·	·	·	·	·	·	·	·	·	$8M	·	$7M	$6M	$6M	·	$5M
Interest Income	$367.0K	$205.0K	$311.0K	$240.0K	$68.0K	$144.0K	$374.0K	$366.0K	$353.0K	$374.0K	$398.0K	$339.0K	$265.0K	$75.0K	$61.0K	$40.0K
Other Non-op	$4M	$-286.0K	$1M	$399.0K	$5M	$3M	$-10M	$2M	$-983.0K	$-1M	$2M	$-2M	$-4M	$963.0K	$4M	$-4M
Pretax Income	$-12M	$339.0K	$7M	$7M	$3M	$-2M	$-17M	$-1M	$-2M	$13M	$-591.0K	$-9M	$-3M	$-9M	$3M	$-13M
Income Tax	$2M	$-1M	$4M	$554.0K	$2M	$-2M	$-119.0K	$1M	$-306.0K	$5M	$3M	$382.0K	$725.0K	$5M	$1M	$1M
Net Income	$-14M	$1M	$2M	$7M	$1M	$-505.0K	$-16M	$-2M	$-2M	$8M	$-4M	$-10M	$-3M	$-14M	$2M	$-14M
EPS (Basic)	$-0.28	$0.03	$0.06	$0.14	$0.03	$-0.01	$-0.40	$-0.05	$-0.05	$0.18	$-0.10	$-0.24	$-0.08	$-0.33	$0.05	$-0.34
EPS (Diluted)	$-0.28	$0.03	$0.06	$0.13	$0.03	$-0.01	$-0.40	$-0.05	$-0.05	$0.18	$-0.10	$-0.24	$-0.08	$-0.33	$0.05	$-0.34
Shares (Basic)	48,541,000	48,074,000	-88,426,000	47,233,000	44,296,000	42,232,000	-83,141,000	41,844,000	41,683,000	41,290,000	-81,325,000	40,881,000	40,755,000	40,432,000	-79,964,000	40,115,000
Shares (Diluted)	48,541,000	49,731,000	-89,223,000	48,775,000	45,378,000	42,232,000	-89,737,000	41,844,000	41,683,000	47,886,000	-81,325,000	40,881,000	40,755,000	40,432,000	-79,964,000	40,115,000
EBITDA	$-8M	$12M	·	$13M	$8M	$8M	·	$4M	$7M	$31M	·	$-1M	$8M	$2M	·	$-4M

Bilanço 26

AORT için Çeyreklik Bilanço verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$77M	$56M	$65M	$73M	$53M	$38M	$53M	$56M	$55M	$51M	·	$53M	$49M	$31M	·	$38M
Receivables	$98M	$92M	$90M	$88M	$91M	$88M	$79M	$76M	$74M	$74M	·	$64M	$65M	$63M	·	$57M
Inventory	$103M	$98M	$92M	$91M	$87M	$82M	$80M	$84M	$81M	$82M	·	$79M	$78M	$76M	·	$73M
Prepaid Expense	$27M	$45M	$43M	$22M	$25M	$20M	$19M	$19M	$20M	$17M	·	$17M	$19M	$20M	·	$17M
Current Assets	$371M	$358M	$358M	$337M	$319M	$287M	$290M	$288M	$285M	$277M	·	$267M	$264M	$241M	·	$238M
PP&E (Net)	$74M	$68M	$65M	$41M	$40M	$38M	$36M	$38M	$37M	$38M	·	$37M	$38M	$39M	·	$36M
Goodwill	$350M	$252M	$254M	$254M	$254M	$245M	$241M	$249M	$244M	$245M	$247M	$243M	$246M	$246M	$244M	$235M
Intangibles	$149M	$120M	$124M	$126M	$129M	$128M	$128M	$135M	$135M	$138M	·	$143M	$147M	$150M	·	$148M
Other Non-current Assets	$15M	$16M	$15M	$29M	$27M	$25M	$24M	$21M	$14M	$13M	·	$8M	$8M	$8M	·	$7M
Total Assets	$1.07B	$883M	$885M	$858M	$838M	$791M	$789M	$803M	$790M	$784M	·	$775M	$778M	$757M	·	$743M
Accounts Payable	$21M	$18M	$16M	$16M	$19M	$12M	$18M	$11M	$12M	$10M	·	$11M	$10M	$9M	·	$11M
Accrued Liabilities	$16M	$17M	$16M	$12M	$11M	$12M	$12M	$16M	$16M	$16M	·	$10M	$10M	$10M	·	$10M
Current Liabilities	$107M	$93M	$102M	$86M	$67M	$52M	$67M	$153M	$51M	$46M	·	$55M	$56M	$44M	·	$46M
Capital Leases	$36M	$34M	$34M	$38M	$39M	$39M	$40M	$41M	$42M	$43M	·	$43M	$40M	$41M	·	$41M
Deferred Tax	$26M	$28M	$24M	$22M	$23M	$22M	$20M	$19M	$22M	$22M	·	$20M	$19M	$24M	·	$34M
Other Non-current Liabilities	$9M	$9M	$9M	$9M	$9M	$8M	$8M	$8M	$8M	$8M	·	$8M	$7M	$7M	·	$7M
Total Liabilities	$626M	$433M	$437M	$419M	$418M	$497M	$513M	$498M	$494M	$489M	·	$503M	$495M	$477M	·	$488M
Long-term Debt	$363M	$215M	$215M	$215M	$216M	$315M	$314M	$314M	$314M	$313M	·	$307M	$308M	$308M	·	$308M
Total Debt	$363M	$215M	·	$215M	$216M	$315M	·	$314M	$314M	$313M	·	$307M	$308M	$308M	·	$308M
Common Stock	$502.0K	$500.0K	$493.0K	$488.0K	$486.0K	$442.0K	$434.0K	$434.0K	$433.0K	$432.0K	·	$425.0K	$424.0K	$424.0K	·	$418.0K
Retained Earnings	$-64M	$-50M	$-51M	$-54M	$-60M	$-62M	$-61M	$-45M	$-42M	$-40M	·	$-44M	$-34M	$-31M	·	$-19M
Treasury Stock	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	·	$15M	$15M	$15M	·	$15M
AOCI	$-12M	$-12M	$-3M	$-2M	$-3M	$-19M	$-25M	$-10M	$-16M	$-14M	·	$-21M	$-16M	$-18M	·	$-45M
Stockholders' Equity	$446M	$450M	$448M	$439M	$420M	$294M	$276M	$305M	$295M	$295M	$282M	$272M	$283M	$280M	$284M	$255M
Liabilities + Equity	$1.07B	$883M	$885M	$858M	$838M	$791M	$789M	$803M	$790M	$784M	·	$775M	$778M	$757M	·	$743M
Shares Outstanding	50,179,000	49,983,000	49,330,000	48,862,000	48,592,000	44,190,000	43,432,000	43,392,000	·	·	42,569,000	42,537,000	42,443,000	42,366,000	41,830,000	41,816,000

Nakit Akışı 16

AORT için Çeyreklik Nakit Akışı verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$7M	$6M	$6M	$6M	$6M	$5M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$5M	$6M
Stock-based Comp	$8M	$8M	$4M	$6M	$6M	$8M	$3M	$4M	$4M	$3M	$4M	$3M	$4M	$3M	$3M	$3M
Deferred Tax	·	·	·	·	·	·	$3M	·	·	·	$6M	·	·	·	·	·
Amort. of Intangibles	$4M	$4M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M
Other Non-cash	·	$-15M	·	·	·	$-30M	·	·	·	$-22M	·	·	·	$-2M	·	·
Operating Cash Flow	$-1M	$1M	$20M	$22M	$15M	$-17M	$10M	$11M	$6M	$-5M	$11M	$7M	$7M	$-6M	$-217.0K	$4M
CapEx	$11M	$8M	$28M	$5M	$3M	$4M	$1M	$4M	$3M	$4M	$3M	$3M	$3M	$3M	$4M	$3M
Investing Cash Flow	$-129M	$-11M	$-31M	$-5M	$-3M	$-4M	$-11M	$-11M	$-3M	$-4M	$-3M	$-2M	$7M	$-3M	$-3M	$-3M
Debt Issued	·	·	$0	$0	$0	$0	$-6M	$160M	$160M	$190M	$0	$0	$0	$0	·	·
Net Debt Issued	·	$0	·	·	·	$-66.0K	·	·	·	$-182M	·	·	·	·	·	·
Stock Issued	$1M	$1M	$3M	$5M	$278.0K	$4M	$443.0K	$2M	$59.0K	$4M	$488.0K	$886.0K	$0	$3M	$24.0K	$1M
Net Stock Activity	·	$1M	·	·	·	$4M	·	·	·	$4M	·	·	·	$3M	·	·
Financing Cash Flow	$152M	$463.0K	$2M	$2M	$3M	$4M	$174.0K	$1M	$-181.0K	$737.0K	$-2M	$-909.0K	$2M	$1M	$-859.0K	$252.0K
Net Change in Cash	$22M	$-9M	$-9M	$20M	$16M	$-16M	$-3M	$1M	$4M	$-8M	$5M	$5M	$18M	$-9M	$2M	$-3M
Free Cash Flow	·	$-7M	·	·	·	$-21M	·	·	·	$-9M	·	·	·	$-8M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-14M	·	·	·	$-18M	·	·

Kârlılık 8

AORT için Çeyreklik Kârlılık verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	64.0%	64.8%	·	65.6%	64.7%	64.2%	·	63.7%	64.6%	64.6%	·	64.0%	65.1%	64.5%	·	63.4%
Operating Margin	-6.7%	5.0%	·	11.1%	7.4%	2.2%	·	4.6%	6.6%	26.0%	·	-1.4%	8.6%	-4.6%	·	-5.3%
Net Margin	-10.7%	1.2%	·	5.7%	1.2%	-0.51%	·	-2.4%	-2.2%	7.7%	·	-11.2%	-3.8%	-16.3%	·	-17.8%
Pretax Margin	-9.3%	0.29%	·	6.2%	3.1%	-2.3%	·	-1.3%	-2.5%	13.1%	·	-10.7%	-3.0%	-10.7%	·	-16.3%
EBITDA Margin	-6.7%	10.4%	·	11.1%	7.4%	7.7%	·	4.6%	6.6%	32.0%	·	-1.4%	8.6%	2.2%	·	-5.3%
ROA	-1.4%	0.17%	·	0.78%	0.17%	-0.06%	·	-0.29%	-0.27%	0.98%	·	-1.3%	-0.44%	-1.8%	·	-1.8%
ROE	-3.1%	0.38%	·	1.8%	0.38%	-0.17%	·	-0.79%	-0.73%	2.6%	·	-3.7%	-1.2%	-4.7%	·	-4.8%
ROIC	-1.2%	3.6%	·	1.8%	0.51%	0.08%	·	1.3%	0.93%	2.5%	·	-0.22%	1.7%	-1.0%	·	-0.80%

Likidite ve Solventlik 5

AORT için Çeyreklik Likidite ve Solventlik verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	3.5	3.9	·	3.9	4.8	5.5	·	1.9	5.6	6.0	·	4.9	4.7	5.5	·	5.2
Quick Ratio	1.6	1.6	·	1.9	2.2	2.4	·	0.9	2.5	2.7	·	2.1	2.0	2.1	·	2.1
Debt / Equity	0.8	0.5	·	0.5	0.5	1.1	·	1.0	1.1	1.1	·	1.1	1.1	1.1	·	1.2
LT Debt / Equity	0.8	0.5	·	0.5	0.5	1.1	·	0.7	1.1	1.1	·	1.1	1.1	1.1	·	1.2
Interest Coverage	·	·	·	·	·	·	·	·	·	3.2	·	-0.2	1.2	-0.6	·	-0.9

Verimlilik 3

AORT için Çeyreklik Verimlilik verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	0.5	0.5	·	0.4	0.5	0.4	·	0.4	0.4	0.4	·	0.4	0.4	0.4	·	0.4
Receivables Turnover	1.3	1.3	·	1.4	1.4	1.2	·	1.4	1.4	1.4	·	1.4	1.5	1.4	·	1.4

Hisse Başına 5

AORT için Çeyreklik Hisse Başına verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$8.88	$9.01	·	$8.98	$8.64	$6.66	·	$7.02	·	·	·	$6.39	$6.66	$6.61	·	$6.10
Revenue / Share	$2.59	$2.34	·	$2.32	$2.49	$2.34	·	$2.29	$2.35	$2.03	·	$2.15	$2.19	$2.06	·	$1.92
Cash Flow / Share	·	$0.02	·	·	·	$-0.40	·	·	·	$-0.11	·	·	·	$-0.15	·	·
Cash / Share	$1.54	$1.12	·	$1.50	$1.10	$0.85	·	$1.29	·	·	·	$1.26	$1.15	$0.73	·	$0.90
EPS (TTM)	$-0.09	$0.18	·	$0.10	$-0.08	$0.07	·	$-0.16	$-0.19	$-0.47	·	$-0.99	$-0.86	$-0.86	·	$-0.27

Değerleme (TTM) 14

AORT için Çeyreklik Değerleme (TTM) verileri
Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$468M	$442M	·	$421M	$406M	$390M	·	$379M	$373M	$358M	·	$337M	$330M	$318M	·	$307M
Net Income TTM	$-4M	$9M	·	$5M	$-4M	$3M	·	$-7M	$-8M	$-19M	·	$-40M	$-35M	$-35M	·	$-11M
Market Cap	$1.13B	$1.83B	·	$2.07B	$1.51B	$1.09B	·	$1.16B	·	·	·	$645M	$730M	$555M	·	$579M
Enterprise Value	$1.41B	$1.99B	·	$2.21B	$1.67B	$1.36B	·	$1.41B	·	·	·	$899M	$988M	$832M	·	$849M
P/E	-249.7	203.4	·	423.4	-388.8	351.1	·	-166.4	-135.0	-45.0	·	-15.3	-20.0	-15.2	·	-51.3
P/S	2.4	4.1	·	4.9	3.7	2.8	·	3.0	·	·	·	1.9	2.2	1.7	·	1.9
P/B	2.5	4.1	·	4.7	3.6	3.7	·	3.8	·	·	·	2.4	2.6	2.0	·	2.3
P / Tangible Book	·	23.2	·	35.5	41.0	·	·	·	·	·	·	·	·	·	·	·
P / Cash Flow	·	1586.1	·	·	·	-64.1	·	·	·	·	·	·	·	-90.2	·	·
P / FCF	·	-267.2	·	·	·	-52.8	·	·	·	·	·	·	·	-66.1	·	·
EV / EBITDA	-169.0	164.1	·	176.3	199.6	179.6	·	322.1	·	·	·	-722.5	128.8	444.3	·	-206.9
EV / FCF	·	-290.5	·	·	·	-66.2	·	·	·	·	·	·	·	-99.2	·	·
EV / Revenue	3.0	4.5	·	5.2	4.1	3.5	·	3.7	·	·	·	2.7	3.0	2.6	·	2.8
Earnings Yield	-0.40%	0.49%	·	0.24%	-0.26%	0.28%	·	-0.60%	-0.74%	-2.2%	·	-6.5%	-5.0%	-6.6%	·	-1.9%

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Gelir Tablosu

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$441M	$389M	$354M	$314M	$299M
Brüt Kâr Marjı %	64.4%	64.0%	64.7%	64.5%	66.1%
Faaliyet Kâr Marjı %	7.6%	10.0%	1.6%	2.0%	2.7%
Net Gelir	$10M	$-13M	$-31M	$-19M	$-15M
Seyreltilmiş Hisse Başı Kâr	$0.21	$-0.32	$-0.75	$-0.48	$-0.38

Bilanço

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Borç / Öz Sermaye	0.5	1.1	1.1	1.1	1.0
Cari Oran	3.5	4.3	4.9	5.0	5.5
Cari Oran	1.5	2.0	2.3	2.0	2.4

Nakit Akışı

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$839.0K	$11M	$11M	$-14M	$-16M

Son Haberler Bu şirketten bahseden son manşetler

Editöryal yönergeler dahilinde başlık seçenekleri oluşturma: Bir ETF Mağazası, Değer Kaybetmiş Bir Medtech'i En Büyük Holdingi Haline Getirdi Nasdaq · 3 ay önce
Güçlü Katalizörler Artivion'u (AORT) Yönlendiriyor Yahoo Finance · 3 ay, 3 hafta önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

📊

Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

Kurumsal Sahipler (13F) 217 dosya · $728.9M toplam · Tarih itibarıyla 30 Haziran 2026

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
42 (+7 önceki Ç'ye göre)	64 (+28 önceki Ç'ye göre)	80 (-7 önceki Ç'ye göre)	47 (-16 önceki Ç'ye göre)	+5.4M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$71.566.000	3.184.974	9,82%	Hisse senetleri
Juniper Investment Company, LLC	$45.386.816	2.019.885	6,23%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$45.043.789	2.004.619	6,18%	Hisse senetleri
FMR LLC	$41.871.497	1.863.440	5,74%	Hisse senetleri
STATE STREET CORP	$41.750.406	1.858.051	5,73%	Hisse senetleri
Ophir Asset Management Pty Ltd	$40.446.180	1.800.008	5,55%	Hisse senetleri
PERCEPTIVE ADVISORS LLC	$39.036.906	1.737.290	5,36%	Hisse senetleri
Conestoga Capital Advisors, LLC	$36.484.539	1.623.700	5,01%	Hisse senetleri
SILVERCREST ASSET MANAGEMENT GROUP LLC	$23.011.325	1.024.091	3,16%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$22.205.281	988.219	3,05%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$21.427.261	953.365	2,94%	Hisse senetleri
DIMENSIONAL FUND ADVISORS LP	$20.062.856	892.873	2,75%	Hisse senetleri
CITADEL ADVISORS LLC	$17.701.821	787.798	2,43%	Hisse senetleri
YARGER WEALTH STRATEGIES, LLC	$15.278.432	634.223	2,10%	Hisse senetleri
ROYCE & ASSOCIATES LP	$14.364.667	639.282	1,97%	Hisse senetleri
WELLINGTON MANAGEMENT GROUP LLP	$11.702.264	520.795	1,61%	Hisse senetleri
Qube Research & Technologies Ltd	$10.704.820	476.405	1,47%	Hisse senetleri
FRED ALGER MANAGEMENT, LLC	$10.406.104	463.111	1,43%	Hisse senetleri
TWO SIGMA ADVISERS, LP	$9.974.907	218.700	1,37%	Hisse senetleri
D. E. Shaw & Co., Inc.	$9.846.714	438.216	1,35%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$9.183.579	408.704	1,26%	Hisse senetleri
Toroso Investments, LLC	$9.018.146	197.723	1,24%	Hisse senetleri
Soleus Capital Management, L.P.	$8.718.360	388.000	1,20%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$8.702.159	387.279	1,19%	Hisse senetleri
Balyasny Asset Management L.P.	$8.584.686	382.051	1,18%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$7.733.095	344.152	1,06%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$6.978.103	310.552	0,96%	Hisse senetleri
KENNEDY CAPITAL MANAGEMENT LLC	$6.611.371	294.231	0,91%	Hisse senetleri
UBS Group AG	$6.026.544	268.204	0,83%	Hisse senetleri
WASATCH ADVISORS LP	$5.726.929	156.388	0,79%	Hisse senetleri
BRIDGER MANAGEMENT, LLC	$4.855.373	132.588	0,67%	Hisse senetleri
Quantinno Capital Management LP	$4.497.191	200.142	0,62%	Hisse senetleri
AMERIPRISE FINANCIAL INC	$4.347.068	193.461	0,60%	Hisse senetleri
FIFTH THIRD BANCORP	$4.170.912	185.621	0,57%	Hisse senetleri
ORBIMED ADVISORS LLC	$3.932.250	175.000	0,54%	Hisse senetleri
Corient Private Wealth LP	$3.578.618	159.262	0,49%	Hisse senetleri
Public Sector Pension Investment Board	$3.298.304	146.787	0,45%	Hisse senetleri
Parkman Healthcare Partners LLC	$3.121.982	138.940	0,43%	Hisse senetleri
Universal- Beteiligungs- und Servicegesellschaft mbH	$2.879.149	128.133	0,40%	Hisse senetleri
VOLORIDGE INVESTMENT MANAGEMENT, LLC	$2.857.263	127.159	0,39%	Hisse senetleri
Summit Creek Advisors LLC	$2.704.354	120.354	0,37%	Hisse senetleri
CONNORS INVESTOR SERVICES INC	$2.700.445	120.180	0,37%	Hisse senetleri
BNP PARIBAS FINANCIAL MARKETS	$2.693.816	119.885	0,37%	Hisse senetleri
Bank of New York Mellon Corp	$2.522.415	112.257	0,35%	Hisse senetleri
RHUMBLINE ADVISERS	$2.373.280	105.621	0,33%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$2.303.872	102.531	0,32%	Hisse senetleri
XTX Topco Ltd	$2.173.905	96.747	0,30%	Hisse senetleri
Swiss National Bank	$1.914.444	85.200	0,26%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$1.912.535	85.115	0,26%	Hisse senetleri
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	$1.875.420	51.213	0,26%	Hisse senetleri
LAZARD ASSET MANAGEMENT LLC	$1.875.301	83.458	0,26%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$1.524.073	67.827	0,21%	Hisse senetleri
ALLIANCEBERNSTEIN L.P.	$1.522.477	41.575	0,21%	Hisse senetleri
Legal & General Group Plc	$1.468.954	65.374	0,20%	Hisse senetleri
CITIGROUP INC	$1.425.856	63.456	0,20%	Hisse senetleri
Squarepoint Ops LLC	$1.424.238	63.384	0,20%	Hisse senetleri
Russell Investments Group, Ltd.	$1.303.125	57.994	0,18%	Hisse senetleri
VICTORY CAPITAL MANAGEMENT INC	$1.193.157	53.100	0,16%	Hisse senetleri
ENVESTNET ASSET MANAGEMENT INC	$1.117.972	49.754	0,15%	Hisse senetleri
Sterling Capital Management LLC	$1.098.918	48.906	0,15%	Hisse senetleri
Sio Capital Management, LLC	$1.089.368	48.481	0,15%	Hisse senetleri
BOOTHBAY FUND MANAGEMENT, LLC	$1.010.521	44.972	0,14%	Hisse senetleri
PRUDENTIAL FINANCIAL INC	$995.219	44.291	0,14%	Hisse senetleri
WELLS FARGO & COMPANY/MN	$937.314	41.714	0,13%	Hisse senetleri
VANGUARD GROUP INC	$898.699	19.704	0,12%	Hisse senetleri
FIRST TRUST ADVISORS LP	$857.657	38.169	0,12%	Hisse senetleri
BlackRock, Inc.	$789.461	35.134	0,11%	Hisse senetleri
Zurcher Kantonalbank (Zurich Cantonalbank)	$738.274	32.856	0,10%	Hisse senetleri
Verition Fund Management LLC	$729.399	32.461	0,10%	Hisse senetleri
Aquatic Capital Management LLC	$712.771	31.721	0,10%	Hisse senetleri
Jain Global LLC	$680.908	30.303	0,09%	Hisse senetleri
JONES FINANCIAL COMPANIES LLLP	$662.072	28.042	0,09%	Hisse senetleri
Brevan Howard Capital Management LP	$652.461	29.037	0,09%	Hisse senetleri
VANGUARD ASSET MANAGEMENT, Ltd	$634.193	28.224	0,09%	Hisse senetleri
JANUS HENDERSON GROUP PLC	$623.335	17.038	0,09%	Hisse senetleri
MetLife Investment Management, LLC	$601.050	26.749	0,08%	Hisse senetleri
Y-Intercept (Hong Kong) Ltd	$600.735	26.735	0,08%	Hisse senetleri
Mariner, LLC	$570.520	25.390	0,08%	Hisse senetleri
TOCQUEVILLE ASSET MANAGEMENT L.P.	$561.750	25.000	0,08%	Hisse senetleri
Illinois Municipal Retirement Fund	$545.010	24.255	0,07%	Hisse senetleri
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$516.855	23.002	0,07%	Hisse senetleri
Walleye Capital LLC	$490.408	21.825	0,07%	Hisse senetleri
Penn Capital Management Company, LLC	$489.689	21.793	0,07%	Hisse senetleri
ALLSTATE CORP	$483.240	21.506	0,07%	Hisse senetleri
EXCHANGE TRADED CONCEPTS, LLC	$476.948	21.226	0,07%	Hisse senetleri
MORGAN STANLEY	$476.588	21.210	0,07%	Hisse senetleri
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$473.241	21.061	0,06%	Hisse senetleri
Louisiana State Employees Retirement System	$420.189	18.700	0,06%	Hisse senetleri
Invesco Ltd.	$409.628	18.230	0,06%	Hisse senetleri
DARK FOREST CAPITAL MANAGEMENT LP	$402.123	17.896	0,06%	Hisse senetleri
Vanguard Global Advisers, LLC	$371.384	16.528	0,05%	Hisse senetleri
Freestone Grove Partners LP	$328.219	14.607	0,05%	Hisse senetleri
NEW YORK STATE COMMON RETIREMENT FUND	$324.287	14.432	0,04%	Hisse senetleri
JOHNSON INVESTMENT COUNSEL INC	$307.008	13.663	0,04%	Hisse senetleri
Police & Firemen's Retirement System of New Jersey	$303.053	13.487	0,04%	Hisse senetleri
DIKER MANAGEMENT LLC	$303.000	13.500	0,04%	Hisse senetleri
OPPENHEIMER ASSET MANAGEMENT INC.	$284.672	12.669	0,04%	Hisse senetleri
GUGGENHEIM CAPITAL LLC	$283.302	12.608	0,04%	Hisse senetleri
ELEVATION POINT WEALTH PARTNERS, LLC	$263.303	11.718	0,04%	Hisse senetleri
Vestmark Advisory Solutions, Inc.	$263.303	11.718	0,04%	Hisse senetleri

Şirket yöneticileri 49 içeriden öğrenenler · 27 yöneticiler · 15 yönetim kurulu üyeleri

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Satışlar 12ay	Net 12ay
James P Mackin	President & CEO	06 Mart 2025 M	865.283	0	$0
David Ashley Lee	Executive VP, COO & CFO	02 Mart 2023 S	347.217	0	$0
Marshall S. Stanton	SVP, Clinical & MD Affair	17 Haziran 2025 S	64.200	0	$0
John E Davis	Chief Commercial Officer	11 Mart 2025 M	208.778	0	$0
Amy Horton	VP, Chief Accounting Officer	06 Mart 2025 S	146.651	0	$0
Matthew A Getz	VP, Human Resources	16 Ağustos 2024 S	34.116	0	$0
Florian Tyrs	VP, Global Operations	27 Şubat 2024 S	21.558	0	$0
Rochelle L. Maney	VP, Quality	26 Şubat 2024 S	44.518	0	$0
Robert C Thomson	VP Research & Development	23 Şubat 2024 A	13.291	0	$0
Dennis B Maier	SVP, Operations	06 Haziran 2023 S	34.724	0	$0
Franz Peter Barthold	VP, Research & Development	08 Kasım 2022 A	32.516	0	$0
Scott B Capps	VP, Clinical Research	12 Mart 2021 F	153.203	0	$0
James M Mcdermid	SVP, CHRO	14 Mart 2019 F	30.806	0	$0
Sherry M Saurini	VP, Quality	14 Mart 2019 F	25.084	0	$0
William Robert Matthews	Senior VP, Operations, Quality	05 Mart 2018 F	39.883	0	$0
David C Gale	VP, Research & Development	16 Kasım 2017 M	77.135	0	$0
Steven G Anderson	Former Executive Chairman	09 Nisan 2015 F	1.271.846	0	$0
Bruce G. Anderson	VP, US Sales &Global Marketing	07 Mart 2015 F	42.106	0	$0
FRONK DAVID	VP, Regulatory Affairs	07 Mart 2015 F	110.559	0	$0
David P. Lang	VP, Int'l Sales & Marketing	26 Şubat 2015 A	73.441	0	$0
Jeffrey W Burris	Vice President & Gen. Counsel	15 Ağustos 2014 M	95.221	0	$0
Gerald B Seery	Sr. VP, Sales and Marketing	30 Kasım 2012 S	71.999	0	$0
Albert E Heacox	Sr. VP Research and Devl	31 Aralık 2011 F	110.144	0	$0
Philip A Theodore	VP, General Counsel	04 Eylül 2007 A	23.100	0	$0
Sidney B Ashmore	Vice President of Marketing	18 Ocak 2006 M	42.728	0	$0
Kirby S Black	Sr. Vice President, R&D	21 Eylül 2004 M	55.131	0	$0
Vander James C Wyk	VP - Product Integrity	14 Eylül 2004 M	36.165	0	$0
Anthony B. Semedo	Yönetim kurulu üyesi	02 Haziran 2026 J	6.325	0	$0
Elizabeth A Hoff	Yönetim kurulu üyesi	22 Mayıs 2025 A	31.389	0	$0
Marna P Borgstrom	Yönetim kurulu üyesi	22 Mayıs 2025 A	49.088	0	$0
Jon W Salveson	Yönetim kurulu üyesi	22 Mayıs 2025 A	129.840	0	$0
Jeffrey H Burbank	Yönetim kurulu üyesi	22 Mayıs 2025 A	53.796	0	$0
Daniel J Bevevino	Yönetim kurulu üyesi	22 Mayıs 2025 A	150.061	0	$0
Bullock James	Yönetim kurulu üyesi	22 Mayıs 2025 A	68.647	0	$0
Thomas F Ackerman	Yönetim kurulu üyesi	22 Mayıs 2025 A	149.896	0	$0
Harvey Morgan	Yönetim kurulu üyesi	30 Ağustos 2021 G	46.342	0	$0
Ronald D Mccall	Yönetim kurulu üyesi	25 Ağustos 2021 S	121.768	0	$0
Elkins C Ronald	Yönetim kurulu üyesi	05 Eylül 2018 S	64.843	0	$0
James Benson	Yönetim kurulu üyesi	02 Ekim 2017 S	54.086	0	$0
John M Cook	Yönetim kurulu üyesi	09 Haziran 2009 M	85.000	0	$0
LACY VIRGINIA C	Yönetim kurulu üyesi	24 Nisan 2007 S	255.280	0	$0
VAN DYNE BRUCE J MD	Yönetim kurulu üyesi	01 Ağustos 2006 A	12.800	0	$0
OSS CAPITAL MANAGEMENT	10% sahip	31 Mayıs 2007 S	1.918.000	0	$0
Lance A Berry	—	14 Ağustos 2026 S	210.112	1	$-20.413
Andrew M Green	—	14 Ağustos 2026 S	59.643	3	$-928.248
Jean F Holloway	—	12 Ağustos 2026 S	184.118	1	$-27.835
Michael S Simpson	—	05 Mart 2021 F	33.698	0	$0
Thomas J Bogenschuetz	—	05 Mayıs 2020 A	23.451	0	$0
Thomas J Lynch	—	02 Kasım 2004 A	5.000	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

Aktivistler ve %5+ sahipler 5 pozisyon

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi	Dosyalandı	Hisse	Durum	Amaç	Başvuru
Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 başvurular	12 Ağustos 2025	4,00%	Değişiklik	—	SEC
CryoLife, Inc., CL Falcon, Inc.	11 Mayıs 2011	—	İlk başvuru	M&A / satış	SEC
Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k)	10 Temmuz 2007	—	İlk başvuru	—	SEC
Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi	02 Aralık 2005	—	İlk başvuru	Pasif yatırım	SEC
Açıklanmayan raporlama kişisi	18 Mart 2005	—	İlk başvuru	Pasif yatırım	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF sahipliği 53 ETF'ler tarafından tutuluyor

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
SAWS · ETF Series Solutions	2,95%	5.817 NS	30 Nisan 2026	N-PORT
HTEC · EXCHANGE TRADED CONCEPTS TRUST	1,77%	26.421 NS	30 Nisan 2026	N-PORT
PSCH · Invesco Exchange-Traded Fund Trust …	0,59%	37.075 SH	08 Ağustos 2026	Günlük
RZG · Invesco Exchange-Traded Fund Trust	0,44%	22.725 SH	08 Ağustos 2026	Günlük
SIXL · EXCHANGE TRADED CONCEPTS TRUST	0,25%	21.547 NS	31 Mayıs 2026	N-PORT
ESSC · Strategy Shares	0,24%	1.691 NS	30 Nisan 2026	N-PORT
XSMO · Invesco Exchange-Traded Fund Trust	0,21%	246.008 SH	08 Ağustos 2026	Günlük
IHI · iShares Trust	0,16%	202.161 SH	08 Ağustos 2026	Günlük
IJT · iShares Trust	0,13%	397.869 SH	08 Ağustos 2026	Günlük
FYC · First Trust Exchange-Traded AlphaDE…	0,11%	31.285 NS	30 Nisan 2026	N-PORT
VIOG · VANGUARD ADMIRAL FUNDS	0,10%	50.848 SH	08 Ağustos 2026	Günlük
QVMS · Invesco Exchange-Traded Fund Trust …	0,08%	7.285 SH	08 Ağustos 2026	Günlük
IWO · iShares Trust	0,08%	419.028 SH	08 Ağustos 2026	Günlük
XJR · iShares Trust	0,07%	5.059 SH	08 Ağustos 2026	Günlük
IJR · iShares Trust	0,06%	2.606.468 SH	08 Ağustos 2026	Günlük
VTWG · VANGUARD SCOTTSDALE FUNDS	0,06%	49.054 SH	08 Ağustos 2026	Günlük
VIOO · VANGUARD ADMIRAL FUNDS	0,05%	148.966 SH	08 Ağustos 2026	Günlük
RSSL · Global X Funds	0,05%	18.968 NS	30 Nisan 2026	N-PORT
SAA · ProShares Trust	0,04%	505 NS	31 Mayıs 2026	N-PORT
DFAS · Dimensional ETF Trust	0,04%	158.121 NS	30 Nisan 2026	N-PORT
IWM · iShares Trust	0,04%	1.162.604 SH	08 Ağustos 2026	Günlük
ISCG · iShares Trust	0,04%	14.407 SH	08 Ağustos 2026	Günlük
RWJ · Invesco Exchange-Traded Fund Trust …	0,04%	28.917 SH	08 Ağustos 2026	Günlük
GSSC · Goldman Sachs ETF Trust	0,03%	14.525 NS	31 Mayıs 2026	N-PORT
EBIT · Harbor ETF Trust	0,03%	101 NS	30 Nisan 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,03%	263.046 SH	08 Ağustos 2026	Günlük
SMDX · Tidal Trust III	0,03%	999 NS	30 Nisan 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,03%	27.103 SH	08 Ağustos 2026	Günlük
ITWO · ProShares Trust	0,02%	2.057 NS	31 Mayıs 2026	N-PORT
FHLC · FIDELITY COVINGTON TRUST	0,02%	18.392 NS	30 Nisan 2026	N-PORT
FAD · First Trust Exchange-Traded AlphaDE…	0,02%	2.917 NS	30 Nisan 2026	N-PORT
SCHA · SCHWAB STRATEGIC TRUST	0,02%	200.917 NS	31 Mayıs 2026	N-PORT
ISCB · iShares Trust	0,02%	2.111 SH	08 Ağustos 2026	Günlük
UWM · ProShares Trust	0,01%	1.609 NS	31 Mayıs 2026	N-PORT
URTY · ProShares Trust	0,01%	1.624 NS	31 Mayıs 2026	N-PORT
JSTC · Tidal Trust I	0,01%	1.526 NS	31 Mayıs 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	495.296 SH	08 Ağustos 2026	Günlük
VHT · VANGUARD WORLD FUND	0,01%	127.662 SH	08 Ağustos 2026	Günlük
WSML · iShares Trust	0,01%	2.264 SH	08 Ağustos 2026	Günlük
DFAC · Dimensional ETF Trust	0,01%	107.410 NS	30 Nisan 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,01%	1.773 NS	31 Mayıs 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	3.861 NS	30 Nisan 2026	N-PORT
HDG · ProShares Trust	0,00%	41 NS	31 Mayıs 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	1.937 NS	30 Nisan 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	8.873 NS	30 Nisan 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	12.377 NS	30 Nisan 2026	N-PORT
ITOT · iShares Trust	0,00%	61.883 SH	08 Ağustos 2026	Günlük
IWV · iShares Trust	0,00%	10.738 SH	08 Ağustos 2026	Günlük
SCHB · SCHWAB STRATEGIC TRUST	0,00%	25.635 NS	31 Mayıs 2026	N-PORT
TILT · FlexShares Trust	0,00%	636 NS	30 Nisan 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	1.463.340 SH	08 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	3.652 SH	08 Ağustos 2026	Günlük
EBI · RBB Fund Trust	0,00%	3 NS	31 Mayıs 2026	N-PORT

Artivion, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı

AORT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

AORT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

Hareketli ortalamalar ve bindirmeler

Hacim

Osilatörler

Momentum ve eğilim

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

AORT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

12 Aylık Fiyat Hedefi

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Son Haberler Bu şirketten bahseden son manşetler

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

Kurumsal Sahipler (13F) 217 dosya · $728.9M toplam · Tarih itibarıyla 30 Haziran 2026

Şirket yöneticileri 49 içeriden öğrenenler · 27 yöneticiler · 15 yönetim kurulu üyeleri

Aktivistler ve %5+ sahipler 5 pozisyon

ETF sahipliği 53 ETF'ler tarafından tutuluyor